Product Information
LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.0366 per EA under NDC 68180051930. Its NADAC has been published 580 times since Jul 15, 2015.
FDA first approved this application on Sep 27, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12.5; 20 mg/1; mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180051930
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; LISINOPRILApproval Type
Generic (ANDA)
FDA Application
ANDA077912FDA Approved
9/27/2006
TE Code
AB
On Market Since
10/4/2006
Pharmacological Classes
Price Statistics
The NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has been published 580 times since Jul 15, 2015, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0366 per EA |
|---|---|
| All-time high | $0.0587 (Oct 13, 2021) |
| All-time low | $0.0311 (Nov 20, 2024) |
| 52-week high | $0.0413 |
| 52-week low | $0.0366 |
| Median price | $0.0412 |
| Average price | $0.0429 |
| Largest weekly change | -29.0% (Nov 20, 2024) |
| Weeks tracked | 580 |
| Tracking since | Jul 15, 2015 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, manufactured by Lupin Pharmaceuticals Inc., is $0.0366 per EA (NDC 68180051930), effective Aug 19, 2026.
How has the price of LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has held within roughly two percent of its current level. It has been tracked across 580 weekly CMS publications since Jul 15, 2015.
What are the highest and lowest recorded NADAC prices for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
Since Jul 15, 2015, the NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has ranged from a low of $0.0311 (Nov 20, 2024) to a high of $0.0587 (Oct 13, 2021), with a median of $0.0412 per EA.
Are there cheaper alternatives to LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB (NDC 68180051930) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.